Literature DB >> 638462

Severe lithium toxicity with "normal" serum concentrations.

J Speirs, S R Hirsch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638462      PMCID: PMC1603458          DOI: 10.1136/bmj.1.6116.815

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function.

Authors:  A R Green; D G Grahame-Smith
Journal:  Neuropharmacology       Date:  1975-02       Impact factor: 5.250

2.  Increased lithium erythrocyte-plasma ratio in manic-depressive psychosis.

Authors:  L Lyttkens; U Söderberg; L Wetterberg
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

3.  Genetic determinant of lithium ion distribution. I. An in vitro monozygotic-dizygotic twin study.

Authors:  E Dorus; G N Pandey; A Frazer; J Mendels
Journal:  Arch Gen Psychiatry       Date:  1974-10

4.  The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.

Authors:  D G Grahame-Smith; A R Green
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

  4 in total
  10 in total

Review 1.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  Cerebellar syndrome in lithium poisoning.

Authors:  D E Jacome
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

Review 3.  Review of clinically important drug interactions with lithium.

Authors:  N S Harvey; S Merriman
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

4.  Interaction of lithium and phenytoin.

Authors:  W A MacCallum
Journal:  Br Med J       Date:  1980-03-01

5.  Lithium neurotoxicity presenting as dementia with therapeutic serum lithium levels.

Authors:  Sarita Soni
Journal:  BMJ Case Rep       Date:  2019-01-17

Review 6.  Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

Authors:  Chi-Tso Chiu; De-Maw Chuang
Journal:  Pharmacol Ther       Date:  2010-08-10       Impact factor: 12.310

7.  Reversible lithium neurotoxicity: review of the literatur.

Authors:  Ivan Netto; Vivek H Phutane
Journal:  Prim Care Companion CNS Disord       Date:  2012

Review 8.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 9.  Psychological effects caused by drugs in overdose.

Authors:  L Evans
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 10.  Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations.

Authors:  Paolo Girardi; Roberto Brugnoli; Giovanni Manfredi; Gabriele Sani
Journal:  Drugs R D       Date:  2016-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.